Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1999 Oct;54(10):929–937. doi: 10.1136/thx.54.10.929

Streptococcus pneumoniae

J Catterall 1
PMCID: PMC1745373  PMID: 10491458

Full Text

The Full Text of this article is available as a PDF (110.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adamou J. E., Wizemann T. M., Barren P., Langermann S. Adherence of Streptococcus pneumoniae to human bronchial epithelial cells (BEAS-2B). Infect Immun. 1998 Feb;66(2):820–822. doi: 10.1128/iai.66.2.820-822.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. AlonsoDeVelasco E., Verheul A. F., Verhoef J., Snippe H. Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines. Microbiol Rev. 1995 Dec;59(4):591–603. doi: 10.1128/mr.59.4.591-603.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Andersson B., Svanborg Edén C. Mechanisms of pneumococcal attachment. Monogr Allergy. 1988;24:44–45. [PubMed] [Google Scholar]
  4. Appelbaum P. C. Epidemiology and in vitro susceptibility of drug-resistant Streptococcus pneumoniae. Pediatr Infect Dis J. 1996 Oct;15(10):932–934. doi: 10.1097/00006454-199610000-00030. [DOI] [PubMed] [Google Scholar]
  5. Austrian R. Pneumococcus: the first one hundred years. Rev Infect Dis. 1981 Mar-Apr;3(2):183–189. doi: 10.1093/clinids/3.2.183. [DOI] [PubMed] [Google Scholar]
  6. Austrian R. Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention. Rev Infect Dis. 1981 Mar-Apr;3 (Suppl):S1–17. doi: 10.1093/clinids/3.supplement_1.s1. [DOI] [PubMed] [Google Scholar]
  7. Benton K. A., Everson M. P., Briles D. E. A pneumolysin-negative mutant of Streptococcus pneumoniae causes chronic bacteremia rather than acute sepsis in mice. Infect Immun. 1995 Feb;63(2):448–455. doi: 10.1128/iai.63.2.448-455.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Berry A. M., Alexander J. E., Mitchell T. J., Andrew P. W., Hansman D., Paton J. C. Effect of defined point mutations in the pneumolysin gene on the virulence of Streptococcus pneumoniae. Infect Immun. 1995 May;63(5):1969–1974. doi: 10.1128/iai.63.5.1969-1974.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Berry A. M., Paton J. C. Sequence heterogeneity of PsaA, a 37-kilodalton putative adhesin essential for virulence of Streptococcus pneumoniae. Infect Immun. 1996 Dec;64(12):5255–5262. doi: 10.1128/iai.64.12.5255-5262.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Boutten A., Dehoux M. S., Seta N., Ostinelli J., Venembre P., Crestani B., Dombret M. C., Durand G., Aubier M. Compartmentalized IL-8 and elastase release within the human lung in unilateral pneumonia. Am J Respir Crit Care Med. 1996 Jan;153(1):336–342. doi: 10.1164/ajrccm.153.1.8542140. [DOI] [PubMed] [Google Scholar]
  11. Briles D. E., Tart R. C., Wu H. Y., Ralph B. A., Russell M. W., McDaniel L. S. Systemic and mucosal protective immunity to pneumococcal surface protein A. Ann N Y Acad Sci. 1996 Oct 25;797:118–126. doi: 10.1111/j.1749-6632.1996.tb52954.x. [DOI] [PubMed] [Google Scholar]
  12. Brown E. J., Hosea S. W., Frank M. M. The role of antibody and complement in the reticuloendothelial clearance of pneumococci from the bloodstream. Rev Infect Dis. 1983 Sep-Oct;5 (Suppl 4):S797–S805. doi: 10.1093/clinids/5.supplement_4.s797. [DOI] [PubMed] [Google Scholar]
  13. Cabellos C., MacIntyre D. E., Forrest M., Burroughs M., Prasad S., Tuomanen E. Differing roles for platelet-activating factor during inflammation of the lung and subarachnoid space. The special case of Streptococcus pneumoniae. J Clin Invest. 1992 Aug;90(2):612–618. doi: 10.1172/JCI115900. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Canvin J. R., Marvin A. P., Sivakumaran M., Paton J. C., Boulnois G. J., Andrew P. W., Mitchell T. J. The role of pneumolysin and autolysin in the pathology of pneumonia and septicemia in mice infected with a type 2 pneumococcus. J Infect Dis. 1995 Jul;172(1):119–123. doi: 10.1093/infdis/172.1.119. [DOI] [PubMed] [Google Scholar]
  15. Chollet-Martin S., Montravers P., Gibert C., Elbim C., Desmonts J. M., Fagon J. Y., Gougerot-Pocidalo M. A. High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome. Infect Immun. 1993 Nov;61(11):4553–4559. doi: 10.1128/iai.61.11.4553-4559.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Chollet-Martin S., Montravers P., Gibert C., Elbim C., Desmonts J. M., Fagon J. Y., Gougerot-Pocidalo M. A. Subpopulation of hyperresponsive polymorphonuclear neutrophils in patients with adult respiratory distress syndrome. Role of cytokine production. Am Rev Respir Dis. 1992 Oct;146(4):990–996. doi: 10.1164/ajrccm/146.4.990. [DOI] [PubMed] [Google Scholar]
  17. Chollet-Martin S., Rousset F., Chastre J., Gibert C., Banchereau J., Gougerot-Pocidalo M. A. Cytokines in adult respiratory distress syndrome. Lancet. 1994 Nov 19;344(8934):1440–1440. doi: 10.1016/s0140-6736(94)90611-4. [DOI] [PubMed] [Google Scholar]
  18. Cohn D. A., Schiffman G. Immunoregulatory role of the spleen in antibody responses to pneumococcal polysaccharide antigens. Infect Immun. 1987 Jun;55(6):1375–1380. doi: 10.1128/iai.55.6.1375-1380.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Courtney H. S. Degradation of connective tissue proteins by serine proteases from Streptococcus pneumoniae. Biochem Biophys Res Commun. 1991 Mar 29;175(3):1023–1028. doi: 10.1016/0006-291x(91)91667-2. [DOI] [PubMed] [Google Scholar]
  20. Cundell D. R., Gerard N. P., Gerard C., Idanpaan-Heikkila I., Tuomanen E. I. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature. 1995 Oct 5;377(6548):435–438. doi: 10.1038/377435a0. [DOI] [PubMed] [Google Scholar]
  21. Cundell D. R., Pearce B. J., Sandros J., Naughton A. M., Masure H. R. Peptide permeases from Streptococcus pneumoniae affect adherence to eucaryotic cells. Infect Immun. 1995 Jul;63(7):2493–2498. doi: 10.1128/iai.63.7.2493-2498.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Cundell D. R., Tuomanen E. I. Receptor specificity of adherence of Streptococcus pneumoniae to human type-II pneumocytes and vascular endothelial cells in vitro. Microb Pathog. 1994 Dec;17(6):361–374. doi: 10.1006/mpat.1994.1082. [DOI] [PubMed] [Google Scholar]
  23. Cundell D. R., Weiser J. N., Shen J., Young A., Tuomanen E. I. Relationship between colonial morphology and adherence of Streptococcus pneumoniae. Infect Immun. 1995 Mar;63(3):757–761. doi: 10.1128/iai.63.3.757-761.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Dehoux M. S., Boutten A., Ostinelli J., Seta N., Dombret M. C., Crestani B., Deschenes M., Trouillet J. L., Aubier M. Compartmentalized cytokine production within the human lung in unilateral pneumonia. Am J Respir Crit Care Med. 1994 Sep;150(3):710–716. doi: 10.1164/ajrccm.150.3.8087341. [DOI] [PubMed] [Google Scholar]
  25. Dillard J. P., Vandersea M. W., Yother J. Characterization of the cassette containing genes for type 3 capsular polysaccharide biosynthesis in Streptococcus pneumoniae. J Exp Med. 1995 Mar 1;181(3):973–983. doi: 10.1084/jem.181.3.973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Dinarello C. A., Cannon J. G. Cytokine measurements in septic shock. Ann Intern Med. 1993 Oct 15;119(8):853–854. doi: 10.7326/0003-4819-119-8-199310150-00013. [DOI] [PubMed] [Google Scholar]
  27. Dintilhac A., Alloing G., Granadel C., Claverys J. P. Competence and virulence of Streptococcus pneumoniae: Adc and PsaA mutants exhibit a requirement for Zn and Mn resulting from inactivation of putative ABC metal permeases. Mol Microbiol. 1997 Aug;25(4):727–739. doi: 10.1046/j.1365-2958.1997.5111879.x. [DOI] [PubMed] [Google Scholar]
  28. Doerschuk C. M., Markos J., Coxson H. O., English D., Hogg J. C. Quantitation of neutrophil migration in acute bacterial pneumonia in rabbits. J Appl Physiol (1985) 1994 Dec;77(6):2593–2599. doi: 10.1152/jappl.1994.77.6.2593. [DOI] [PubMed] [Google Scholar]
  29. Doerschuk C. M., Winn R. K., Coxson H. O., Harlan J. M. CD18-dependent and -independent mechanisms of neutrophil emigration in the pulmonary and systemic microcirculation of rabbits. J Immunol. 1990 Mar 15;144(6):2327–2333. [PubMed] [Google Scholar]
  30. Donnelly S. C., Strieter R. M., Reid P. T., Kunkel S. L., Burdick M. D., Armstrong I., Mackenzie A., Haslett C. The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann Intern Med. 1996 Aug 1;125(3):191–196. doi: 10.7326/0003-4819-125-3-199608010-00005. [DOI] [PubMed] [Google Scholar]
  31. Doyle N. A., Bhagwan S. D., Meek B. B., Kutkoski G. J., Steeber D. A., Tedder T. F., Doerschuk C. M. Neutrophil margination, sequestration, and emigration in the lungs of L-selectin-deficient mice. J Clin Invest. 1997 Feb 1;99(3):526–533. doi: 10.1172/JCI119189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Fang G. D., Fine M., Orloff J., Arisumi D., Yu V. L., Kapoor W., Grayston J. T., Wang S. P., Kohler R., Muder R. R. New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) 1990 Sep;69(5):307–316. doi: 10.1097/00005792-199009000-00004. [DOI] [PubMed] [Google Scholar]
  33. Feldman C., Munro N. C., Jeffery P. K., Mitchell T. J., Andrew P. W., Boulnois G. J., Guerreiro D., Rohde J. A., Todd H. C., Cole P. J. Pneumolysin induces the salient histologic features of pneumococcal infection in the rat lung in vivo. Am J Respir Cell Mol Biol. 1991 Nov;5(5):416–423. doi: 10.1165/ajrcmb/5.5.416. [DOI] [PubMed] [Google Scholar]
  34. Feldman C., Read R., Rutman A., Jeffery P. K., Brain A., Lund V., Mitchell T. J., Andrew P. W., Boulnois G. J., Todd H. C. The interaction of Streptococcus pneumoniae with intact human respiratory mucosa in vitro. Eur Respir J. 1992 May;5(5):576–583. [PubMed] [Google Scholar]
  35. García E., Arrecubieta C., Muñoz R., Mollerach M., López R. A functional analysis of the Streptococcus pneumoniae genes involved in the synthesis of type 1 and type 3 capsular polysaccharides. Microb Drug Resist. 1997 Spring;3(1):73–88. doi: 10.1089/mdr.1997.3.73. [DOI] [PubMed] [Google Scholar]
  36. Geelen S., Bhattacharyya C., Tuomanen E. The cell wall mediates pneumococcal attachment to and cytopathology in human endothelial cells. Infect Immun. 1993 Apr;61(4):1538–1543. doi: 10.1128/iai.61.4.1538-1543.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Giesecke J., Fredlund H. Increase in pneumococcal bacteraemia in Sweden. Lancet. 1997 Mar 8;349(9053):699–700. doi: 10.1016/S0140-6736(05)60136-5. [DOI] [PubMed] [Google Scholar]
  38. Gillespie S. H. Aspects of pneumococcal infection including bacterial virulence, host response and vaccination. J Med Microbiol. 1989 Apr;28(4):237–248. doi: 10.1099/00222615-28-4-237. [DOI] [PubMed] [Google Scholar]
  39. Gray B. M., Dillon H. C., Jr Natural history of pneumococcal infections. Pediatr Infect Dis J. 1989 Jan;8(1 Suppl):S23–S25. [PubMed] [Google Scholar]
  40. Greenberger M. J., Kunkel S. L., Strieter R. M., Lukacs N. W., Bramson J., Gauldie J., Graham F. L., Hitt M., Danforth J. M., Standiford T. J. IL-12 gene therapy protects mice in lethal Klebsiella pneumonia. J Immunol. 1996 Oct 1;157(7):3006–3012. [PubMed] [Google Scholar]
  41. Greenberger M. J., Strieter R. M., Kunkel S. L., Danforth J. M., Goodman R. E., Standiford T. J. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J Immunol. 1995 Jul 15;155(2):722–729. [PubMed] [Google Scholar]
  42. Greenberger M. J., Strieter R. M., Kunkel S. L., Danforth J. M., Laichalk L. L., McGillicuddy D. C., Standiford T. J. Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia. J Infect Dis. 1996 Jan;173(1):159–165. doi: 10.1093/infdis/173.1.159. [DOI] [PubMed] [Google Scholar]
  43. Haslett C. Granulocyte apoptosis and inflammatory disease. Br Med Bull. 1997;53(3):669–683. doi: 10.1093/oxfordjournals.bmb.a011638. [DOI] [PubMed] [Google Scholar]
  44. Haslett C. Resolution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes. Clin Sci (Lond) 1992 Dec;83(6):639–648. doi: 10.1042/cs0830639. [DOI] [PubMed] [Google Scholar]
  45. Haslett C., Shen A. S., Feldsien D. C., Allen D., Henson P. M., Cherniack R. M. 111Indium-labeled neutrophil migration into the lungs of bleomycin-treated rabbits assessed noninvasively by external scintigraphy. Am Rev Respir Dis. 1989 Sep;140(3):756–763. doi: 10.1164/ajrccm/140.3.756. [DOI] [PubMed] [Google Scholar]
  46. Hebert J. C., O'Reilly M., Gamelli R. L. Protective effect of recombinant human granulocyte colony-stimulating factor against pneumococcal infections in splenectomized mice. Arch Surg. 1990 Aug;125(8):1075–1078. doi: 10.1001/archsurg.1990.01410200141022. [DOI] [PubMed] [Google Scholar]
  47. Henrichsen J. Six newly recognized types of Streptococcus pneumoniae. J Clin Microbiol. 1995 Oct;33(10):2759–2762. doi: 10.1128/jcm.33.10.2759-2762.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Heumann D., Barras C., Severin A., Glauser M. P., Tomasz A. Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect Immun. 1994 Jul;62(7):2715–2721. doi: 10.1128/iai.62.7.2715-2721.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Hofmann J., Cetron M. S., Farley M. M., Baughman W. S., Facklam R. R., Elliott J. A., Deaver K. A., Breiman R. F. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med. 1995 Aug 24;333(8):481–486. doi: 10.1056/NEJM199508243330803. [DOI] [PubMed] [Google Scholar]
  50. Hopkins H., Stull T., Von Essen S. G., Robbins R. A., Rennard S. I. Neutrophil chemotactic factors in bacterial pneumonia. Chest. 1989 May;95(5):1021–1027. doi: 10.1378/chest.95.5.1021. [DOI] [PubMed] [Google Scholar]
  51. Håkansson A., Carlstedt I., Davies J., Mossberg A. K., Sabharwal H., Svanborg C. Aspects on the interaction of Streptococcus pneumoniae and Haemophilus influenzae with human respiratory tract mucosa. Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 2):S187–S191. doi: 10.1164/ajrccm/154.4_Pt_2.S187. [DOI] [PubMed] [Google Scholar]
  52. Janoff E. N., Breiman R. F., Daley C. L., Hopewell P. C. Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives. Ann Intern Med. 1992 Aug 15;117(4):314–324. doi: 10.7326/0003-4819-117-4-314. [DOI] [PubMed] [Google Scholar]
  53. Johnson A. P., Speller D. C., George R. C., Warner M., Domingue G., Efstratiou A. Prevalence of antibiotic resistance and serotypes in pneumococci in England and Wales: results of observational surveys in 1990 and 1995. BMJ. 1996 Jun 8;312(7044):1454–1456. doi: 10.1136/bmj.312.7044.1454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Jones H. A., Clark R. J., Rhodes C. G., Schofield J. B., Krausz T., Haslett C. In vivo measurement of neutrophil activity in experimental lung inflammation. Am J Respir Crit Care Med. 1994 Jun;149(6):1635–1639. doi: 10.1164/ajrccm.149.6.7516252. [DOI] [PubMed] [Google Scholar]
  55. Jonsson S., Musher D. M., Chapman A., Goree A., Lawrence E. C. Phagocytosis and killing of common bacterial pathogens of the lung by human alveolar macrophages. J Infect Dis. 1985 Jul;152(1):4–13. doi: 10.1093/infdis/152.1.4. [DOI] [PubMed] [Google Scholar]
  56. Kalin M. Pneumococcal serotypes and their clinical relevance. Thorax. 1998 Mar;53(3):159–162. doi: 10.1136/thx.53.3.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Kawakami M., Tsutsumi H., Kumakawa T., Abe H., Hirai M., Kurosawa S., Mori M., Fukushima M. Levels of serum granulocyte colony-stimulating factor in patients with infections. Blood. 1990 Nov 15;76(10):1962–1964. [PubMed] [Google Scholar]
  58. Kelly R., Greiff D. Toxicity of pneumococcal neuraminidase. Infect Immun. 1970 Jul;2(1):115–117. doi: 10.1128/iai.2.1.115-117.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Kelly T., Dillard J. P., Yother J. Effect of genetic switching of capsular type on virulence of Streptococcus pneumoniae. Infect Immun. 1994 May;62(5):1813–1819. doi: 10.1128/iai.62.5.1813-1819.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Kilian M., Mestecky J., Schrohenloher R. E. Pathogenic species of the genus Haemophilus and Streptococcus pneumoniae produce immunoglobulin A1 protease. Infect Immun. 1979 Oct;26(1):143–149. doi: 10.1128/iai.26.1.143-149.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Knecht J. C., Schiffman G., Austrian R. Some biological properties of Pneumococcus type 37 and the chemistry of its capsular polysaccharide. J Exp Med. 1970 Sep 1;132(3):475–487. doi: 10.1084/jem.132.3.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Lawrence E., Van Eeden S., English D., Hogg J. C. Polymorphonuclear leukocyte (PMN) migration in streptococcal pneumonia: comparison of older PMN with those recently released from the marrow. Am J Respir Cell Mol Biol. 1996 Mar;14(3):217–224. doi: 10.1165/ajrcmb.14.3.8845171. [DOI] [PubMed] [Google Scholar]
  63. Macfarlane J. T., Finch R. G., Ward M. J., Macrae A. D. Hospital study of adult community-acquired pneumonia. Lancet. 1982 Jul 31;2(8292):255–258. doi: 10.1016/s0140-6736(82)90334-8. [DOI] [PubMed] [Google Scholar]
  64. Marik P., Kraus P., Sribante J., Havlik I., Lipman J., Johnson D. W. Hydrocortisone and tumor necrosis factor in severe community-acquired pneumonia. A randomized controlled study. Chest. 1993 Aug;104(2):389–392. doi: 10.1378/chest.104.2.389. [DOI] [PubMed] [Google Scholar]
  65. Masure H. R., Campbell E. A., Cundell D. R., Pearce B. J., Sandros J., Spellerberg B. A new genetic strategy for the analysis of virulence and transformation in Streptococcus pneumoniae. Dev Biol Stand. 1995;85:251–260. [PubMed] [Google Scholar]
  66. Mizgerd J. P., Meek B. B., Kutkoski G. J., Bullard D. C., Beaudet A. L., Doerschuk C. M. Selectins and neutrophil traffic: margination and Streptococcus pneumoniae-induced emigration in murine lungs. J Exp Med. 1996 Aug 1;184(2):639–645. doi: 10.1084/jem.184.2.639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Molloy R. G., Mannick J. A., Rodrick M. L. Cytokines, sepsis and immunomodulation. Br J Surg. 1993 Mar;80(3):289–297. doi: 10.1002/bjs.1800800308. [DOI] [PubMed] [Google Scholar]
  68. Moussa K., Michie H. J., Cree I. A., McCafferty A. C., Winter J. H., Dhillon D. P., Stephens S., Brown R. A. Phagocyte function and cytokine production in community acquired pneumonia. Thorax. 1994 Feb;49(2):107–111. doi: 10.1136/thx.49.2.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Murphy T. F., Sethi S. Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1992 Oct;146(4):1067–1083. doi: 10.1164/ajrccm/146.4.1067. [DOI] [PubMed] [Google Scholar]
  70. Musher D. M., Chapman A. J., Goree A., Jonsson S., Briles D., Baughn R. E. Natural and vaccine-related immunity to Streptococcus pneumoniae. J Infect Dis. 1986 Aug;154(2):245–256. doi: 10.1093/infdis/154.2.245. [DOI] [PubMed] [Google Scholar]
  71. Musher D. M., Groover J. E., Reichler M. R., Riedo F. X., Schwartz B., Watson D. A., Baughn R. E., Breiman R. F. Emergence of antibody to capsular polysaccharides of Streptococcus pneumoniae during outbreaks of pneumonia: association with nasopharyngeal colonization. Clin Infect Dis. 1997 Mar;24(3):441–446. doi: 10.1093/clinids/24.3.441. [DOI] [PubMed] [Google Scholar]
  72. Musher D. M., Luchi M. J., Watson D. A., Hamilton R., Baughn R. E. Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide. J Infect Dis. 1990 Apr;161(4):728–735. doi: 10.1093/infdis/161.4.728. [DOI] [PubMed] [Google Scholar]
  73. Natanson C., Hoffman W. D., Suffredini A. F., Eichacker P. Q., Danner R. L. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med. 1994 May 1;120(9):771–783. doi: 10.7326/0003-4819-120-9-199405010-00009. [DOI] [PubMed] [Google Scholar]
  74. Nelson S., Mason C. M., Kolls J., Summer W. R. Pathophysiology of pneumonia. Clin Chest Med. 1995 Mar;16(1):1–12. [PubMed] [Google Scholar]
  75. Pallares R., Liñares J., Vadillo M., Cabellos C., Manresa F., Viladrich P. F., Martin R., Gudiol F. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med. 1995 Aug 24;333(8):474–480. doi: 10.1056/NEJM199508243330802. [DOI] [PubMed] [Google Scholar]
  76. Paton J. C., Andrew P. W., Boulnois G. J., Mitchell T. J. Molecular analysis of the pathogenicity of Streptococcus pneumoniae: the role of pneumococcal proteins. Annu Rev Microbiol. 1993;47:89–115. doi: 10.1146/annurev.mi.47.100193.000513. [DOI] [PubMed] [Google Scholar]
  77. Paton J. C., Berry A. M., Lock R. A. Molecular analysis of putative pneumococcal virulence proteins. Microb Drug Resist. 1997 Spring;3(1):1–10. doi: 10.1089/mdr.1997.3.1. [DOI] [PubMed] [Google Scholar]
  78. Perry F. E., Catterall J. R. The pneumococcus: host-organism interactions and their implications for immunotherapy and immunoprophylaxis. Thorax. 1994 Oct;49(10):946–950. doi: 10.1136/thx.49.10.946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Perry F. E., Elson C. J., Greenham L. W., Catterall J. R. Interference with the oxidative response of neutrophils by Streptococcus pneumoniae. Thorax. 1993 Apr;48(4):364–369. doi: 10.1136/thx.48.4.364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Perry F. E., Elson C. J., Mitchell T. J., Andrew P. W., Catterall J. R. Characterisation of an oxidative response inhibitor produced by Streptococcus pneumoniae. Thorax. 1994 Jul;49(7):676–683. doi: 10.1136/thx.49.7.676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Pons J. L., Mandement M. N., Martin E., Lemort C., Nouvellon M., Mallet E., Lemeland J. F. Clonal and temporal patterns of nasopharyngeal penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae stains in children attending a day care center. J Clin Microbiol. 1996 Dec;34(12):3218–3222. doi: 10.1128/jcm.34.12.3218-3222.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Puren A. J., Feldman C., Savage N., Becker P. J., Smith C. Patterns of cytokine expression in community-acquired pneumonia. Chest. 1995 May;107(5):1342–1349. doi: 10.1378/chest.107.5.1342. [DOI] [PubMed] [Google Scholar]
  83. Rayner C. F., Jackson A. D., Rutman A., Dewar A., Mitchell T. J., Andrew P. W., Cole P. J., Wilson R. Interaction of pneumolysin-sufficient and -deficient isogenic variants of Streptococcus pneumoniae with human respiratory mucosa. Infect Immun. 1995 Feb;63(2):442–447. doi: 10.1128/iai.63.2.442-447.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Riley I. D., Douglas R. M. An epidemiologic approach to pneumococcal disease. Rev Infect Dis. 1981 Mar-Apr;3(2):233–245. doi: 10.1093/clinids/3.2.233. [DOI] [PubMed] [Google Scholar]
  85. Robbins J. B., Austrian R., Lee C. J., Rastogi S. C., Schiffman G., Henrichsen J., Mäkelä P. H., Broome C. V., Facklam R. R., Tiesjema R. H. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis. 1983 Dec;148(6):1136–1159. doi: 10.1093/infdis/148.6.1136. [DOI] [PubMed] [Google Scholar]
  86. Rubins J. B., Charboneau D., Fasching C., Berry A. M., Paton J. C., Alexander J. E., Andrew P. W., Mitchell T. J., Janoff E. N. Distinct roles for pneumolysin's cytotoxic and complement activities in the pathogenesis of pneumococcal pneumonia. Am J Respir Crit Care Med. 1996 Apr;153(4 Pt 1):1339–1346. doi: 10.1164/ajrccm.153.4.8616564. [DOI] [PubMed] [Google Scholar]
  87. Rubins J. B., Charboneau D., Paton J. C., Mitchell T. J., Andrew P. W., Janoff E. N. Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia. J Clin Invest. 1995 Jan;95(1):142–150. doi: 10.1172/JCI117631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Scanlon K. L., Diven W. F., Glew R. H. Purification and properties of Streptococcus pneumoniae neuraminidase. Enzyme. 1989;41(3):143–150. doi: 10.1159/000469069. [DOI] [PubMed] [Google Scholar]
  89. Shapiro E. D., Berg A. T., Austrian R., Schroeder D., Parcells V., Margolis A., Adair R. K., Clemens J. D. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med. 1991 Nov 21;325(21):1453–1460. doi: 10.1056/NEJM199111213252101. [DOI] [PubMed] [Google Scholar]
  90. Sniadack D. H., Schwartz B., Lipman H., Bogaerts J., Butler J. C., Dagan R., Echaniz-Aviles G., Lloyd-Evans N., Fenoll A., Girgis N. I. Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children--implications for vaccine strategies. Pediatr Infect Dis J. 1995 Jun;14(6):503–510. [PubMed] [Google Scholar]
  91. Spellerberg B., Cundell D. R., Sandros J., Pearce B. J., Idanpaan-Heikkila I., Rosenow C., Masure H. R. Pyruvate oxidase, as a determinant of virulence in Streptococcus pneumoniae. Mol Microbiol. 1996 Feb;19(4):803–813. doi: 10.1046/j.1365-2958.1996.425954.x. [DOI] [PubMed] [Google Scholar]
  92. Sundberg-Kövamees M., Holme T., Sjögren A. Interaction of the C-polysaccharide of Streptococcus pneumoniae with the receptor asialo-GM1. Microb Pathog. 1996 Oct;21(4):223–234. doi: 10.1006/mpat.1996.0057. [DOI] [PubMed] [Google Scholar]
  93. Tazi A., Nioche S., Chastre J., Smiéjan J. M., Hance A. J. Spontaneous release of granulocyte colony-stimulating factor (G-CSF) by alveolar macrophages in the course of bacterial pneumonia and sarcoidosis: endotoxin-dependent and endotoxin-independent G-CSF release by cells recovered by bronchoalveolar lavage. Am J Respir Cell Mol Biol. 1991 Feb;4(2):140–147. doi: 10.1165/ajrcmb/4.2.140. [DOI] [PubMed] [Google Scholar]
  94. Toews G. B., Vial W. C. The role of C5 in polymorphonuclear leukocyte recruitment in response to Streptococcus pneumoniae. Am Rev Respir Dis. 1984 Jan;129(1):82–86. doi: 10.1164/arrd.1984.129.1.82. [DOI] [PubMed] [Google Scholar]
  95. Tomasz A. Choline in the cell wall of a bacterium: novel type of polymer-linked choline in Pneumococcus. Science. 1967 Aug 11;157(3789):694–697. doi: 10.1126/science.157.3789.694. [DOI] [PubMed] [Google Scholar]
  96. Tuomanen E. I., Austrian R., Masure H. R. Pathogenesis of pneumococcal infection. N Engl J Med. 1995 May 11;332(19):1280–1284. doi: 10.1056/NEJM199505113321907. [DOI] [PubMed] [Google Scholar]
  97. Tuomanen E., Rich R., Zak O. Induction of pulmonary inflammation by components of the pneumococcal cell surface. Am Rev Respir Dis. 1987 Apr;135(4):869–874. doi: 10.1164/arrd.1987.135.4.869. [DOI] [PubMed] [Google Scholar]
  98. Vered M., Schutzbank T., Janoff A. Inhibitors of human neutrophil elastase in extracts of Streptococcus pneumoniae. Am Rev Respir Dis. 1984 Dec;130(6):1118–1124. doi: 10.1164/arrd.1984.130.6.1118. [DOI] [PubMed] [Google Scholar]
  99. Vincent J. L. Search for effective immunomodulating strategies against sepsis. Lancet. 1998 Mar 28;351(9107):922–923. doi: 10.1016/S0140-6736(05)60595-8. [DOI] [PubMed] [Google Scholar]
  100. Watson D. A., Musher D. M., Verhoef J. Pneumococcal virulence factors and host immune responses to them. Eur J Clin Microbiol Infect Dis. 1995 Jun;14(6):479–490. doi: 10.1007/BF02113425. [DOI] [PubMed] [Google Scholar]
  101. Weiser J. N., Austrian R., Sreenivasan P. K., Masure H. R. Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect Immun. 1994 Jun;62(6):2582–2589. doi: 10.1128/iai.62.6.2582-2589.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Westendorp R. G., Langermans J. A., Huizinga T. W., Elouali A. H., Verweij C. L., Boomsma D. I., Vandenbroucke J. P., Vandenbrouke J. P. Genetic influence on cytokine production and fatal meningococcal disease. Lancet. 1997 Jan 18;349(9046):170–173. doi: 10.1016/s0140-6736(96)06413-6. [DOI] [PubMed] [Google Scholar]
  103. Wilson R., Dowling R. B., Jackson A. D. The biology of bacterial colonization and invasion of the respiratory mucosa. Eur Respir J. 1996 Jul;9(7):1523–1530. doi: 10.1183/09031936.96.09071523. [DOI] [PubMed] [Google Scholar]
  104. Winkelstein J. A., Tomasz A. Activation of the alternative complement pathway by pneumococcal cell wall teichoic acid. J Immunol. 1978 Jan;120(1):174–178. [PubMed] [Google Scholar]
  105. Wizemann T. M., Moskovitz J., Pearce B. J., Cundell D., Arvidson C. G., So M., Weissbach H., Brot N., Masure H. R. Peptide methionine sulfoxide reductase contributes to the maintenance of adhesins in three major pathogens. Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7985–7990. doi: 10.1073/pnas.93.15.7985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. van Dissel J. T., van Langevelde P., Westendorp R. G., Kwappenberg K., Frölich M. Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet. 1998 Mar 28;351(9107):950–953. doi: 10.1016/S0140-6736(05)60606-X. [DOI] [PubMed] [Google Scholar]
  107. van der Poll T., Keogh C. V., Buurman W. A., Lowry S. F. Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice. Am J Respir Crit Care Med. 1997 Feb;155(2):603–608. doi: 10.1164/ajrccm.155.2.9032201. [DOI] [PubMed] [Google Scholar]
  108. van der Poll T., Keogh C. V., Guirao X., Buurman W. A., Kopf M., Lowry S. F. Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J Infect Dis. 1997 Aug;176(2):439–444. doi: 10.1086/514062. [DOI] [PubMed] [Google Scholar]
  109. van der Poll T., Marchant A., Keogh C. V., Goldman M., Lowry S. F. Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis. 1996 Nov;174(5):994–1000. doi: 10.1093/infdis/174.5.994. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES